Latest Governance News

Comet Ridge has made significant strides in its Mahalo Gas Hub development, approving upstream FEED and progressing pipeline connections, supported by a strong cash position of $19.3 million. These developments position the company to address Australia's tightening east coast gas market.

Botala Energy has secured critical environmental approvals for its Serowe CBM Project and successfully raised A$1.87 million, positioning the company for commercial gas production in Southern Africa.

Augustus Minerals reveals encouraging molybdenum and copper intersections from deep diamond drilling at Minnie Springs, highlighting promising mineralisation trends within its Ti-Tree Project.

Duxton Farms has secured a strategic lease over the Wildman Agricultural Precinct in the Northern Territory, marking a significant expansion of its mixed farming portfolio and signaling a shift towards high-value irrigated cropping.

Golden Horse Minerals has successfully listed on the ASX, raising A$18 million to fund exploration across a consolidated 130km strike in Western Australia's Southern Cross Greenstone Belt. The company is gearing up for a major drilling campaign at the historic Hopes Hill gold mine.

Coda Minerals has significantly enhanced the economic outlook of its Elizabeth Creek Copper-Cobalt Project, with a pre-tax NPV7 rising to $1.18 billion and a post-tax NPV7 increase of 57% to $802 million. The company also secured $5.1 million in fresh capital to accelerate exploration and drilling activities in 2025.

IVE Group Limited has scheduled its half-year financial results release for February 24, 2025, alongside a notable governance change with Paul Selig moving from Executive to Non-Executive Director.

Patriot Lithium Limited has made significant strides in acquiring and exploring copper projects in Zambia while navigating complex negotiations for its key Gorman Lithium Project in Canada.

Pancontinental Energy reports encouraging technical progress on its PEL 87 project with improved reservoir confidence and ongoing drilling success in Namibia’s Orange Basin, underpinning a solid cash position.

Mesoblast has secured FDA approval for Ryoncil®, the first mesenchymal stromal cell therapy for steroid-refractory acute graft versus host disease in children, while raising A$260 million to accelerate clinical trials and commercial rollout.

Botanix Pharmaceuticals has initiated the commercial rollout of Sofdra, its FDA-approved treatment for primary axillary hyperhidrosis, with first prescriptions dispensed and a fully trained sales force deployed. The company anticipates meaningful revenue growth starting in the first quarter of 2025, backed by strong payer contracts and a robust cash position.

QEM Limited has marked significant progress in its Julia Creek Vanadium and Energy Project, securing key government approvals and raising $2.76 million to advance development and environmental studies.